The tweet was deleted by the author.
But we saved everything 🙂.
Phathom Pharmaceuticals has made available the replay of its recent fireside chat at the Jefferies Global Healthcare Conference. President and CEO Steve Basta and Chief Financial and Business Officer Sanjeev Narula addressed the company's recent business momentum and outlined its commercial strategy centered on gastrointestinal treatments.
The presentation highlights how Phathom Pharmaceuticals is advancing its position in the GI market. Investors and industry stakeholders can now access the recording for more insights into the company's strategic priorities and current performance.
Phathom has been active on the investor conference circuit in recent months, participating in a series of events during May and June to share business updates with stakeholders, according to a recent announcement. The company also continues to honor the legacy of founder Dr. Tachi Yamada and his contributions to GI medicine, as noted in an earlier company statement. These activities provide further context to Phathom’s ongoing focus in the gastrointestinal sector.